LOH

You have access
Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer
TAMARA CACEV, EMILIJA ZAPLETAL, VESNA MUSANI, IVANA RAKO, BOZO LONCAR, GORANA ARALICA and SANJA KAPITANOVIC

Anticancer Research May 2018, 38 (5) 2841-2848;
You have access
Frequency of the Loss of Heterozygosity of the NF2 Gene in Sporadic Spinal Schwannomas
RAIMUNDO MIRANDA DE CARVALHO, CARLA DE CASTRO SANT' ANNA, GIOVANNY REBOUÇAS PINTO, ERIC HOMERO ALBUQUERQUE PASCHOAL, FABRICIO MESQUITA TUJI, BARBARA DO NASCIMENTO BORGES, PAULO CARDOSO SOARES, ALBERTO GOMES FERREIRA JÚNIOR, JUAN ANTONIO REY, LUIZ CLÁUDIO LOPES CHAVES and ROMMEL RODRIGUEZ BURBANO

Anticancer Research April 2018, 38 (4) 2149-2154;
You have access
Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22
CARSTEN HOLZMANN, DIRK KOCZAN, THOMAS LOENING, BIRGIT ROMMEL and JOERN BULLERDIEK

Anticancer Research May 2017, 37 (5) 2233-2237;
You have access
Utility of ATP7B in Prediction of Response to Platinum-based Chemotherapy in Urothelial Bladder Cancer
SEBASTIAN CHRISTOPH SCHMID, TIBOR SCHUSTER, THOMAS HORN, JÜRGEN GSCHWEND, UWE TREIBER and GREGOR WEIRICH

Anticancer Research September 2013, 33 (9) 3731-3737;

Main menu